Booth (#7326) will highlight new product introductions, key
innovations, and AI-enabled advancements from the company’s
comprehensive portfolio of Imaging, Ultrasound, and digital
solutions designed to optimize patient care and increase
operational efficiencies
GE HealthCare (Nasdaq: GEHC) will highlight more than 40
innovations, including several key artificial intelligence
(AI)-enabled technologies within the Imaging, Ultrasound, and
digital space at the Radiological Society of North America’s (RSNA)
2023 Annual Meeting taking place Nov. 26-30 in Chicago, IL. Each
connected care solution is designed to better support clinicians,
improve patient care, and increase health system efficiency at a
time when healthcare system challenges include rising levels of
radiologist burnout and shortages.
The Association of American Medical Colleges (AAMC) projects a
shortage of up to 41,900 radiologists in the United States in
2033i, while a 2022 survey of 13,000 U.S. physicians found that 49%
of radiologists reported feeling burned out.ii Further exacerbating
the situation is the coming “silver tsunami,” when by the year
2030, more than 1.4 billion of the world’s population is expected
to be over 60 years oldiii, placing additional burden on overworked
radiologists since nearly a third of all scans are performed on
older adults.
“GE HealthCare works to address radiology workforce challenges
by focusing on the root causes of burnout, innovating to better
support clinicians and helping providers deliver care when and
where people need it,” said Peter Arduini, CEO of GE HealthCare.
“Through our smart devices, streamlined disease state focus, and
digital solutions, we’re bringing data together in the right place
at the right time for providers, solving for inefficiencies in
workflow, enabling precision care, and helping improve patient
outcomes. With a history of innovation spanning more than a
century, our goal at GE HealthCare is to solve the healthcare
challenges of today, tomorrow, and well into the future.”
Offering human–focused precision patient care across critical
pathways
GE HealthCare innovations highlighted at the RSNA booth include
technologies and solutions that are designed to seamlessly
integrate along clinical care pathways, including oncology,
cardiology, and neurology. By using GE HealthCare integrated
technologies and diagnostics, clinicians deliver a more personal,
precise, and human-focused approach across the care continuum.
Theranostics Pathway Manager Tile, on Command
Center, aims to offer health care providers an easy-to-use
application that is designed to simplify the burdensome work of
coordinating the oncology care pathway and identifying and tracking
potential theranostics candidates - work that historically has been
manual and tedious. AIR Recon DL, which has scanned almost
16 million patients to dateiv, can help reduce scan time by up to
50% and provide exceptionally high image qualityv. SIGNA PET/MR
AIRvi, which can also be utilized with AIR Recon DL, may be a
useful tool to help clinicians with diagnosis, staging and
monitoring of various diseases from cancer to neurological diseases
like Alzheimer’s. The system also integrates technologies like AIR
Coils to help enhance patient comfort and is equipped with Motion
Free Brainvii to aid in mitigation of motion-related image
distortion.
Advancing care through AI-enabled and deep learning
innovations
GE HealthCare is dedicated to enhancing patient outcomes and is
actively shaping the future of healthcare by advancing AI and deep
learning, streamlining workflows, creating efficiencies, and
leveraging strategic collaborations. For the second year in a row,
GE HealthCare topped the U.S. Food and Drug Administration
(FDA) list of AI-enabled medical devices with the most AI
authorizations of any medtech company, with 58.
A number of these AI and deep learning solutions, including
new solution introductions, will be demonstrated on various
systems and devices throughout the booth:
- New at RSNA:
- SIGNA Championviii is a brand new 1.5T scanner designed
to offer true patient comfort and high-performance scans in a wide
bore system, with access to premium technologies such as AIR Recon
DL, Sonic DL and AIR Coils. It also has AI-enabled workflow
features designed to support efficiency and image quality
regardless of the experience level of the user.
- Revolution Ascend Platform is a new CT solution with
built-in scalability for onsite CT detector coverage upgrades that
helps enable healthcare systems to invest in the clinical
capabilities they need today, while enabling growth in the future –
without replacing the gantry. This builds on the success of the
similarly scalable Revolution Apex Platform, which will be
adding the new ECG-less Cardiacix,x feature designed to help
clinicians acquire images without the aid of the patient’s ECG
signal/trace.
- MyBreastAI Suitexi, provides an all-in-one platform that
integrates a comprehensive collection of AI tools that can
seamlessly deploy AI to the breast imaging workflow.
- Critical Care Suite 2.1, expands triage capabilities
with FDA clearance of new AI that detects and localizes a suspected
pneumothorax (PTX) – providing immediate notification and overlay
on-device for the presence or absence of PTX.
- AI-enabled Ultrasound solutions:
- Venue Family point-of-care ultrasound systems, now with
Caption Guidance AI-driven technology, provides real-time guidance
to users for capturing diagnostic-quality cardiac images.
- LOGIQ E10 Series, now featuring Verisound Digital & AI
Solutions, are ultrasound systems that provide capabilities for
full body imaging, leveraging the power of AI to drive workflow
efficiency and advanced tools to help support clinical
decisions.
- Deep Learning portfolio:
- Effortless Recon DL, a portfolio of deep learning-based
solutions that can help improve image quality and help better
inform clinical decision-making, continues to expand with the
development of True Enhance DLxii for CT, designed to further
enhance its capabilities across multiple imaging practices.
“Health systems and providers are facing several core challenges
in managing efficient workflows, including limited ability to
adjust staffing, burnout among radiologists and technologists, and
variations in imaging equipment across sites, resulting in
inefficient processes as well as training burden,” said Jan Makela,
president and CEO of Imaging at GE HealthCare. “We are uniquely
positioned to help providers leverage imaging data across
healthcare systems, connecting longitudinal data and layering it
with analytics and AI to provide a full view into a patient’s
journey, helping to solve diagnosis challenges and develop
personalized approaches for better patient outcomes.”
GE HealthCare offers next-generation solutions for streamlining
workflows and increasing efficiency, including the following
innovations that will be showcased:
- Recently launched efficiency innovations:
- Imaging 360 for Operations 2.0, which is designed to
help improve radiology efficiency optimization through operational
analytics, dose analytics, scheduling capabilities and now, remote
scan assistance.
- Part of Imaging 360 for Operations 2.0, the recently launched
Digital Expert Access with remote scanning is the first FDA
510(k)-cleared device to enable remote patient scanning on GE
HealthCare MR systems. It enables the sharing of expertise, best
practices, and in-the-moment advice, as well as real-time, remote
console control and remote patient scanning from locations inside
and outside of the radiology suite and across multiple clinical
facilities/physical locations.
- GE HealthCare has also recently signed an exclusive
distribution agreement with IONIC Health. IONIC Health’s
FDA 510(k)-pending nCommand Litexiii technology is designed to
provide a multi-vendor, multi-modality remote scanning
solution.
- Effortless Workflow, a collection of CT, MR, and
Molecular Imaging solutions launched as part of GE HealthCare’s
Effortless Imaging portfolio, which intelligently automates
time-consuming tasks to improve many aspects of imaging from
pre-scan to post-scan, like automatically positioning patients and
providing easy access to hospital protocols – helping to
personalize scans for each patient with significantly less
effort.
- Cardiology efficiency innovations:
- Allia IGS Pulse, with new features including
INTERACT Touch, is the latest addition to the company’s image
guided system (IGS) offerings designed to improve workflow for the
diagnosis and treatment of cardiovascular disease. With just one
click, users can access all their essential functions to make it
their own personalized workplace and use third-party devices
through a seamless workflow.
- CardioVisio for Atrial Fibrillation (AFib), a
digital tool designed to assist clinicians in visualizing
longitudinal data relevant for disease progression from multiple
data sources, and driving evidence-based clinical decision support
directed by up to date AFib guidelines
- Vscan Air SL, the latest addition to the Vscan Air
family, is a handheld, wireless ultrasound imaging system designed
for rapid cardiac and vascular assessments to help clinicians
accelerate diagnoses and treatment decisions at the point of
care.
- Ultrasound efficiency innovations:
- ViewPoint 6.14, the latest version of the ViewPoint
image management and reporting system that offers simple and
efficient reporting in clinical settings where time is of the
essence.
Leading up to RSNA 2023 and building on its commitment to
collaboration, GE HealthCare also announced a number of new grants
and strategic collaborations with health systems, academic and
research institutions, and more:
- Notably, GE HealthCare received a $44 million grant from the
Bill & Melinda Gates Foundation and signed a separate
$44 million contract with the Biomedical Advanced Research and
Development Authority (BARDA) to develop AI-augmented
ultrasound technology for clinicians to perform rapid
assessments.
- GE HealthCare is taking the industrial lead role in a project
to develop a platform and AI algorithms with the goal of
identifying individuals at risk of developing Alzheimer’s disease.
The €21 million project, PREDICTOM, is part of the
Innovative Health Initiative (IHI), a public-private partnership
between the European Union and the European life science
industries. It includes 30 partners from academia, business, civil
society, and hospitals across 15 countries, and is led by
Stavanger University Hospital, Norway.
- GE HealthCare is exploring, along with clinical collaborators,
how AI can help predict patient response to immunotherapies. A
recent study conducted in collaboration on a pan-cancer
cohort with the Vanderbilt University Medical Center and the
University Medicine Essen in Germany reported a 70-80%
accuracy.
- Additional collaborations focused on driving efficiencies,
personalizing care, enhancing imaging capabilities, and uncovering
new treatment options include those with Mass General
Brigham, Mayo Clinic, University Hospitals (UH),
Stanford Medicine, Novo Nordisk, SOFIE
Biosciences and Nucleus RadioPharma.
For more information on GE HealthCare and these innovative
solutions at RSNA, visit Booth 7326, our press kit, or the
RSNA 2023 events page.
About GE HealthCare Technologies Inc.
GE HealthCare is a leading global medical technology,
pharmaceutical diagnostics, and digital solutions innovator,
dedicated to providing integrated solutions, services, and data
analytics to make hospitals more efficient, clinicians more
effective, therapies more precise, and patients healthier and
happier. Serving patients and providers for more than 100 years, GE
HealthCare is advancing personalized, connected, and compassionate
care, while simplifying the patient’s journey across the care
pathway. Together our Imaging, Ultrasound, Patient Care Solutions,
and Pharmaceutical Diagnostics businesses help improve patient care
from diagnosis, to therapy, to monitoring. We are an $18.3 billion
business with 50,000 employees working to create a world where
healthcare has no limits.
Follow us on Facebook, LinkedIn, Twitter, Instagram, and
Insights for the latest news, or visit our website
https://www.gehealthcare.com/ for more information.
_____________________________________________________
i “AAMC Report Reinforces Mounting Physician Shortage.” AAMC, 11
June, 2021,
https://www.aamc.org/news/press-releases/aamc-report-reinforces-mounting-physician-shortage
ii Bailey, Christopher, Bailey, Allison M., et al. Understanding
and Appreciating Burnout in Radiologists. RadioGraphics 2022 42:5,
E137-E139. https://pubs.rsna.org/doi/full/10.1148/rg.220037
iii World Health Organization, “Aging and Health,” World Health
Organization Newsroom, October 1, 2022. https://www.who.int/
iv Calculated by IB data with estimation 20 scans per day, 5.5
working day in a week, fully start using AIR™ Recon DL 4 weeks
after delivery, as of Oct 31, 2023.
v GE HealthCare Data on file
vi SIGNA PET/MR AIR is a premium configuration of SIGNA PET/MR.
Not available for sale in all regions.
vii Not CE Marked. Not available for sale in all regions.
viii SIGNA Champion is 510(k) pending at the U.S. FDA. Not
available for sale in the United States. Not yet CE marked. Not
available in all regions.
ix ECG-less Cardiac is 510(k) pending at the U.S FDA. Not
available for sale in the United States. Not available in all
regions.
x Exclusively available on GE HealthCare’s Revolution Apex Elite
160mm detector configuration.
xi MyBreastAI suite is a commercial offering that includes an AI
platform optimized for Mammography, ProFound Dectection for DBT,
SecondLook for 2D Mammography and PowerLook® Density Assessment.
These three applications are provided by iCAD. MyBreastAI Suite is
compatible with the latest versions of iCAD, Inc. as of November
14, 2023.
xii True Enhance DL is 510(k) pending at the U.S FDA. Not
available for sale in the United States. Not available in all
regions.
xiii nCommand Lite is 510(k) pending at the U.S. FDA. Not
available for sale in the United States. Not yet CE marked. Not
available in all regions.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20231126412038/en/
Karin Dalsin Global Communications Director M 612.219.2855
karin.dalsin@ge.com
GE HealthCare Technologies (NASDAQ:GEHC)
Historical Stock Chart
From Jun 2024 to Jul 2024
GE HealthCare Technologies (NASDAQ:GEHC)
Historical Stock Chart
From Jul 2023 to Jul 2024